Dr. Bouman is Chief Executive Officer. She has been with Kiadis Pharma since early 2004. Prior to joining Kiadis Pharma, Dr. Bouman was Vice President Licensing and Technology at DSM pharmaceutical products. She has worked for almost 10 years at DSM in different positions. Manja Bouman holds a PhD in Biochemistry from the University of New York, USA.
Mr. van Heekeren is Chief Financial Officer. Before joining Kiadis Pharma he was Executive Director, Head Global Finance & Control at Organon, part of Schering–Plough. He worked for Organon for more than 10 years and held management positions in various countries. Robbert van Heekeren holds a Masters degree in Economics from theTilburg University, The Netherlands and a Masters degree in Industrial Engineering & Management Science from the Eindhoven University of Technology, The Netherlands.
Dr. Lambert is Vice-President Regulatory Affairs. Dr. Lambert has over 5 years of experience in Regulatory Affairs with Pharming and Genzyme and prior to that 9 years of experience with the Dutch Medicinal Evaluation Board. At Genzyme Dr. Lambert was responsible for obtaining regulatory approval in Europe for Genzyme’s product for Pompe’s disease in Europe. Marijke Lambert holds a PhD in Immunology from the University of Leiden, The Netherlands.
Ms. Hoppe is General Counsel & Corporate Secretary. She has over 15 years of experience in legal affairs and worked for various biotechnology companies including Gist-Brocades and DSM. Margot Hoppe has a Masters degree in law and political science from the Erasmus University of Rotterdam, The Netherlands.
